What is the recommended treatment for a child with typical dermatophyte (ringworm) infection, including topical therapy for body, groin, or foot lesions and oral therapy for scalp involvement?

Ringworm Treatment in Pediatrics

Treatment Based on Anatomical Site

For scalp ringworm (tinea capitis), oral antifungal therapy is mandatory—topical therapy alone is completely ineffective and should never be used as monotherapy. 1 For body, groin, or foot infections, topical therapy is first-line for localized disease, while oral agents are reserved for extensive involvement, treatment failure, or immunocompromised patients. 1

---

Tinea Capitis (Scalp) Treatment Algorithm

Step 1: Collect Specimens and Start Treatment

• Obtain scalp scrapings, hair pluck, brush sampling, or swab for KOH microscopy and fungal culture before initiating therapy whenever possible. 2
• Start treatment immediately without waiting for culture results if any cardinal signs are present: scaling, lymphadenopathy, alopecia, or kerion. 2

Step 2: Organism-Directed Therapy

For Trichophyton species (most common in North America):

• Terbinafine is the preferred first-line agent due to superior efficacy and shorter treatment duration. 1, 2
• Weight-based dosing for 2-4 weeks: 1
  • Children <20 kg: 62.5 mg daily
  • Children 20-40 kg: 125 mg daily
  • Children >40 kg: 250 mg daily
• Gastrointestinal disturbances and rashes occur in <8% of children. 2

For Microsporum species:

• Griseofulvin is the preferred first-line agent and the only licensed treatment for tinea capitis in many countries. 1, 2, 3
• Dosing for 6-8 weeks: 1, 3
  • Children <50 kg: 15-20 mg/kg/day (typically 125-500 mg daily in divided doses based on weight)
  • Children >50 kg: 1 g/day
• Critical pitfall: Terbinafine fails against Microsporum because it cannot be incorporated into hair shafts in prepubertal children and doesn't reach the scalp surface where arthroconidia are located. 2

Step 3: Adjunctive Measures

• Add topical antifungal therapy (ketoconazole or selenium sulfide shampoo) to reduce transmission. 2
• Screen and treat all family members and close contacts, especially for T. tonsurans infections. 2
• Cleanse hairbrushes and combs with bleach or 2% sodium hypochlorite solution. 2
• Children receiving appropriate systemic and adjunctive topical therapy can attend school—exclusion is unnecessary. 2

Step 4: Special Considerations for Kerion

• Initiate oral antifungal therapy immediately when kerion is identified, without awaiting culture results. 2
• Add topical or oral corticosteroids to alleviate severe inflammatory symptoms. 2
• Recognize that kerion represents a delayed inflammatory host response to fungi, not bacterial infection—do not delay antifungal therapy. 1, 2

Step 5: Monitor for Treatment Endpoint

• The definitive endpoint is mycological cure (negative microscopy and culture), not just clinical improvement. 1, 2
• Repeat mycology sampling at the end of standard treatment period, then monthly until mycological clearance is documented. 1, 2
• If clinical improvement occurs but mycology remains positive, continue current therapy for an additional 2-4 weeks. 1
• If no initial clinical improvement, switch to second-line therapy (itraconazole 5 mg/kg/day for 2-4 weeks or fluconazole). 2

Common Pitfall: Dermatophytid Reactions

• Pruritic papular eruptions may occur after treatment initiation, representing a cell-mediated response to dying dermatophytes. 1, 2
• Do not discontinue antifungal therapy—treat symptomatically with topical corticosteroids while continuing the antifungal regimen. 1, 2

---

Tinea Corporis, Cruris, and Pedis (Body, Groin, Foot) Treatment

First-Line: Topical Therapy for Localized Disease

• Apply terbinafine 1% gel once daily for 1-2 weeks as first-line treatment for mild to moderate infections. 1, 4
• Alternative topical options include ciclopirox 0.77% cream/gel twice daily for 4 weeks or naftifine ointment twice daily for 4 weeks. 1
• Topical allylamines (terbinafine) may have slightly higher cure rates and shorter treatment courses than azoles. 5

Oral Therapy for Extensive or Resistant Disease

• Terbinafine 250 mg daily for 1-2 weeks is particularly effective against T. tonsurans, with an 86% mycological cure rate. 1
• Itraconazole 100 mg daily for 15 days achieves an 87% mycological cure rate and is effective against both Trichophyton and Microsporum species. 1

Monitoring and Safety

• Obtain baseline liver function tests and complete blood count before initiating terbinafine or itraconazole, especially in patients with pre-existing hepatic abnormalities. 1, 4
• Critical drug interactions with itraconazole: Enhanced toxicity with warfarin, certain antihistamines, antipsychotics, midazolam, digoxin, and simvastatin. Itraconazole is contraindicated in heart failure. 1, 4

Prevention of Recurrence

• Always wear protective footwear in public bathing facilities, gyms, and hotel rooms to avoid re-exposure to T. rubrum. 1
• Apply antifungal powders (miconazole, clotrimazole, or tolnaftate) in shoes and on feet. 1

---

Key Diagnostic Confirmation Points

• Obtain mycological confirmation with KOH microscopy and fungal culture before initiating systemic therapy whenever possible. 1, 4
• Collect specimens by scraping from the active border of lesions, not the center. 4
• Mount in 10-30% KOH and examine microscopically for hyphae and arthroconidia for rapid preliminary diagnosis. 4
• Culture on Sabouraud agar with cycloheximide for at least 2 weeks (3 weeks if T. verrucosum suspected from cattle exposure) for definitive species identification. 1, 4